At a Glance
On 9 October 2026, the Union Health Ministry described a proposed amendment to the Drugs Rules, 1945, that would extend prescription-drug advertising restrictions to licensed retailers, wholesalers and distributors.
Key points
- The proposal concerns medicines in Schedule H, H1 and X.
- It would require prior Central Government sanction for covered advertising by drug sale and distribution licence holders.
- The draft was notified as G.S.R. 861(E), dated 28 September 2026, and invites stakeholder objections and suggestions.
India relevance
Pharmacies, distributors and clinicians should distinguish a proposed regulatory change from rules already in force.
Limitations
This is a draft proposal, not confirmation that the new sub-rule is already effective. Read the Gazette for exact language and comment deadline.
Official sources
PIB release, 9 October 2026 | Draft Gazette notification
Regulatory information, not legal or medical advice.
यह लेख उपयोगी लगा? Share करें